LDHA and Familial prostate cancer: Ultimately, hyperpolarized 13C MRSI may provide a highly personalized approach for prostate cancer therapy by: (i) stratifying patients into those who would benefit most from tumor glycolysis inhibition; (ii) enabling early determination of hitting the therapeutic target (Ldha inhibition/LDHA activity), and (iii) providing a better prediction of treatment response.